Superangels

Activity from announced rounds

Activity in this selectionOct 19, 2026 · Jul 22, 2026

Superangels is the Munich early-stage investor whose official portfolio identifies Sodex, Sedivention and sci2sci.

Recorded funding activity

Sodex develops construction-site technology. Sedivention develops a cryoablation treatment for obesity, while sci2sci manages research data and lineage. The firm remains distinct from its Growth Fund and unrelated Superangels namesakes.

Sources
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$1.4M
1 disclosed · full round size, not this investor’s share

By stage

Pre-seed2

By primary sector

AI1
Enterprise software1

By country

Germany2

Rounds

2 in this selection
PLACED

AI sales and labour-market data platform helping recruitment agencies find employers for their candidates.

~€1.8MFirst institutional pre-seed financing
Participant
sci2sci

An AI data-governance platform for biotech and pharma that connects fragmented research and operational data, preserves its lineage and permissions, and grounds AI-assisted work in verifiable evidence.

€1.2MPre-Seed
Participant